Sam Brusco, Associate Editor01.25.23
Tyber Medical has named industry veteran James Abraham for its newly created chief commercial officer role, and Damien Sabilla to the post of chief financial officer (CFO).
Abraham has over 30 years’ experience in the orthopedic device industry, including many executive positions at start-ups to multi-nationals NuVasive (managing director and VP of Australia and New Zealand) and Stryker (GM and area VP of the Orthopaedics and Trauma division). He’s also had roles as president, chief operating officer, and executive VP in spine, biologic, trauma, and total joint markets.
"Creating the chief commercial officer role is a bold new step for us. We are thrilled to have Jim on board to take our product commercialization to the next level," Tyber Medical CEO Jeff Tyber told the press. "Jim's strong leadership and extensive career in executive commercial positions, as well as overseeing global operations, business and product development and mergers and acquisitions, makes him the ideal talent to work with our high-impact team and help us continue to exceed our growth targets."
Sibilla has over 20 years of financial management expertise, with qo in the medical device industry. He was international controller for Globus Medical and CFO with Invata.
"We are very excited to have Damien join our executive leadership team," said Tyber. "His financial management expertise in the CFO role will allow us to further develop our global strategic plan with our commercial partnerships and continue our rapid growth path."
Abraham has over 30 years’ experience in the orthopedic device industry, including many executive positions at start-ups to multi-nationals NuVasive (managing director and VP of Australia and New Zealand) and Stryker (GM and area VP of the Orthopaedics and Trauma division). He’s also had roles as president, chief operating officer, and executive VP in spine, biologic, trauma, and total joint markets.
"Creating the chief commercial officer role is a bold new step for us. We are thrilled to have Jim on board to take our product commercialization to the next level," Tyber Medical CEO Jeff Tyber told the press. "Jim's strong leadership and extensive career in executive commercial positions, as well as overseeing global operations, business and product development and mergers and acquisitions, makes him the ideal talent to work with our high-impact team and help us continue to exceed our growth targets."
Sibilla has over 20 years of financial management expertise, with qo in the medical device industry. He was international controller for Globus Medical and CFO with Invata.
"We are very excited to have Damien join our executive leadership team," said Tyber. "His financial management expertise in the CFO role will allow us to further develop our global strategic plan with our commercial partnerships and continue our rapid growth path."